期刊文献+

乙肝病毒前C基因区1896位点变异的实验研究 被引量:6

Clinical analysis of hapatitis B virus precore region nucleartide 1896 mutations
下载PDF
导出
摘要 目的探讨慢性乙肝病人血清HBV DNA前C基因区nt1896的变异情况及其与HBV DNA水平及转氨酶(ALT)关系。方法将172例慢性乙肝患者分为两组:大三阳组(106例)和小三组(66例)。检测ALT、HBV DNA及前C区nt1896的变异情况。结果大三阳组与小三阳组HBV DNA阳性率有显著差异(P<0.05),nt1896变异率无显著差异(P>0.05)。小三阳患者中ALT升高组(>40 U/L)HBV DNA(+)患者nt1896变异率100%,而ALT正常组HBV DNA(+)患者nt1896变异率30%(3/10)(P<0.05)。结论大三阳和小三阳慢性乙型肝炎病人都存在较高的前C区nt1896变异率(P>0.05)。前C区nt1896变异可能是影响HBV DNA复制的一个因素。 Objective To detect chronic hapafifis B patients hapatitis B virus(HBV) precore region mutations at nuclearfide 1896(nt-1896) and to devdop the rehtionship between the results and the amnotransferase (ALT) with the level of DNA.Methods To divided the patients into two groups: HBsAg( + )/HBeAg( + )/HBcAb( + ) group and HBsAg( + )/HBeAb( + )/HBcAb( + ) group.Test the patients' liver function, HBV DNA and study the mutation at nt-1896 further. Results There was marked difference betwecn two groups with HBV DNA( + ) rate( P 〈 0.05 ), but no difference with nt- 1896 mutation rate( P 〉 0.05). The patients with HBsAg( + )/HBOAb( + )/HBOAb( + ),ALT higher than normal range group mutation rate was 100% (15/15),ALT normal range group mutation rate was 30% (3/10) ( P 〈 0.05 ). Conclusion Both groups patients of chronic hapatitis B had a high mutation rate at nt1896( P 〉 0.05).Maybe the mutation at nt1896 in precore is one of the factors which affect HBV DNA copy.
出处 《中国实验诊断学》 北大核心 2009年第3期340-342,共3页 Chinese Journal of Laboratory Diagnosis
关键词 乙型肝炎病毒 前C基因区 1896位点 变异 HBV preeore region nueleartide 1896 mutation
  • 相关文献

参考文献5

二级参考文献35

  • 1骆抗先,杨洁,李秀惠,章廉,梁炽森.前C区A_(83)点突变在乙型肝炎病毒感染中的分布[J].中华医学杂志,1994,74(8):478-480. 被引量:42
  • 2邱望龙,姚集鲁.乙型肝炎病毒前C区变异与临床[J].国外医学(流行病学.传染病学分册),1996,23(1):14-17. 被引量:6
  • 3Ruggiero V, Tavernier J, Fiers W, Baglioni C. Induction of the synthesis of tumor necrosis factor receptors by Interferon-gamma.J Immunol 1986; 136:2445-2450.
  • 4Niitsuma H, Ishii M, Miura M, Toyota T. Detection of HBV precore mutation by PCR-RFLP. Nippon Rinsho 1995; 53 Suppl(Pt 2): 316-320.
  • 5Chu CM. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatoceUular carcinoma. J Gastroenterol Hepatol 2000; 15(Suppl):E25-30.
  • 6Bertoletti A, Sette A, Chisari FV, Penna A, Giuberti T, Levrero M, De Carli M, Fiaccadori F, Ferrari C. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 1994; 369:407-410.
  • 7Ohta A, Sekimoto M, Sato M, Koda T, Nishimura S, Iwakura Y,Sekikawa K, Nishimura T. Indispensable role for TNF-alpha and IFN-gamma at the effector phase of liver injury mediated by Th1 cells specific to hepatitis B virus surface antigen. J Immunol 2000;165:956-961.
  • 8Muto Y, Nouri-Aria KT, Meager A, Alexander GJ, Eddleston AL,Williams R. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 1988; 2:72-74.
  • 9Tanaka Y, Takahashi A, Watanabe K, Takayama K, Yahata T,Habu T, Nishimura T. A pivotal role of IL-12 in Thl-dependent mouse liver iniury. Int Immunol 1996; 8:569-576.
  • 10Lehmann V, 16reudenberg MA, Galanos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and Dgalactosamine-treated mice. J Exp Med 1987: 165:657-663.

共引文献44

同被引文献37

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部